Company Number: 15214943

Analysis Date: 2025-07-29 13:13 UTC

1. Credit Opinion: DECLINE
   GCG LTD is a very recently incorporated micro entity (established October 2023) with minimal financial history. Its latest accounts show net current liabilities of £6,784 (current liabilities exceed current assets), indicating working capital deficiency and potential liquidity constraints. Though the company reports net assets of £1,811, this is a very modest capital base with no evidence yet of revenue generation or profitability. The director is the sole significant controller, but there is no track record of operational or financial performance. Given the weak liquidity position and lack of trading history, the company is not currently a suitable candidate for credit extension without substantial additional security or guarantees.

2. Financial Strength:
   The balance sheet shows fixed assets of £8,595 and current assets of £4,905, but current liabilities of £11,689, resulting in negative net current assets of £6,784. The small positive net assets (£1,811) represent minimal equity invested. This fragile financial structure with a working capital deficit indicates vulnerability to cash flow shocks. As a micro entity with only one employee and no audit, financial transparency is limited. The company’s financial strength is weak at this stage.

3. Cash Flow Assessment:
   The reported negative net current assets point to a shortfall in liquid resources to meet short-term obligations. Without evidence of cash inflows or profitable operations, liquidity risk is high. The company’s ability to generate cash from operations is unproven. The sole director’s capital injection appears minimal. Overall, cash flow capacity is insufficient for debt servicing under normal credit facility terms.

4. Monitoring Points:

• Progress in generating revenue and moving to positive working capital
• Improvement in net current assets ratio and liquidity ratios
• Timely filing of accounts and confirmation statements
• Stability in management and any changes in shareholding or control
• Any new funding or capital injections to strengthen equity base